INS and Alzheimer disease: Insulin-stimulated pT1135Rictor was slightly lower in untreated AD subjects than in healthy controls (p = 0.05) and was significantly increased following simufilam treatment (p < 0.01 at Day 14 and p < 0.001 at Day 28 vs. Day 0).